NCT01618006View on ClinicalTrials.gov

Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

August 31, 2013

Conditions
Postoperative; Dysfunction Following Cardiac Surgery
Interventions
DRUG

Aspirin

Aspirin 81mg po daily x 7days or end of hospitalization. First dose administered on post op day 1.

DRUG

Aspirin

Aspirin 325mg po daily x 7days or end of hospitalization. First dose administered on post op day 1.

DRUG

Aspirin

Aspirin 81mg po four times daily x 7days or end of hospitalization. First dose administered on post op day 1.

Trial Locations (1)

L8L2X2

Hamilton General Hospital, Hamilton

All Listed Sponsors
lead

Hamilton Health Sciences Corporation

OTHER

NCT01618006 - Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery | Biotech Hunter | Biotech Hunter